Open Access Open Access  Restricted Access Subscription or Fee Access

The University of California, Davis, collaborative model for biotechnology education and training

Judith Ann Kjelstrom


UC Davis and its partners are addressing the need for innovation and entrepreneurship in graduate education and training. This paper will showcase the Designated Emphasis in Biotechnology graduate education program, cross-disciplinary partnerships and technology brokering. These interactions can bring diverse groups of individuals together to translate ideas into real world applications. The creation of intellectual and human capital at universities must be linked to financial capital and social capital. This can be accomplished by creating dense social networks. PhD programs in science and engineering must be transformed in order to stay relevant in the 21st century. UC Davis has been addressing these issues for close to 20 years and is now seeing significant outcomes.


technology brokering; translational; entrepreneurship; Designated Emphasis in Biotechnology; Big Bang; SARTA

Full Text:




Hargadon, Andrew. (2003) How Breakthroughs Happen: The Surprising Truth About How Companies Innovate. Harvard Business School Press.

UC Davis Newservice. (Nov. 2001) $5M commitment to establish new institute for innovation and entrepreneurship.

The University of California Office of the President Economic Impact Report. (2011).

Meyers, Frederick J. and Claire Pomeroy. (Sept. 28, 2011). UC Davis Advocates for New Approaches to Biomedical Research; Creating the Future Biomedical Research Workforce. Science Translational Medicine. Vol 3 Issue 102: 1-2.

UC Davis Partnerships for Innovation Program - Medical Technology Commercialization Clinic.

Kjelstrom, J.A. and Denneal Jamison-McClung. (2008). UC Davis Biotechnology Programs. In: Y. Friedman (ed.) Best Practices in Biotechnology Education. Logos Press. pp. 85-112.

NRC Report of the National Academy. (2009) A New Biology for the 21st Century ISBN-10: 0-309-14488-4.

The Woodrow Wilson National Fellowship Foundation. (2005) The Responsive PhD.

Taylor,M. (2011) Reform the PhD system or close down. Nature 472 (261) doi:10.1038/472261a. [Published online 20 April 2011|

Statement of John P. Holdren, Director-designate, Office of Science and Technology Policy. (February 2009)

The Path Forward: The Future of Graduate Education in the United States. Princeton (April 2010)

NSF, Science and Engineering Indicators 2010 (NSF 10-01) (January, 2010)

Milano, C. (July 2009) Venturing In New Ventures. A special article on Entrepreneurship. Science.

Biotech Education. (March 2008) Career Profile Section. Nature Reviews. Vol.7.

Guimond Gravagna, Nicole. (2009). Creating alternatives in science. Journal of Commercial Biotechnology. 15 (2):161–170.

Fenton GM, C Chi-Ham and S Boettiger. (2007). Freedom to Operate: The Law Firms Approach and Role. In: A Krattiger, RT Mahoney, L Nelsen, et al. (eds.). Intellectual Proper¬ty Management in Health and Agricultural Innovation: A Handbook of Best Practices MIHR: Oxford, U.K., and PIPRA: Davis, U.S.A.



  • There are currently no refbacks.

Copyright © thinkBiotech LLC